SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth, Inc. (BTH), Zillow, Inc. (Z) And SinoHub, Inc. (SIHI) And Investigation Of Peregrine Pharmaceuticals, Inc. (PPHM)

NEW YORK, Dec. 19, 2012 /PRNewswire/ --

Blyth, Inc.

Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the District of Connecticut on behalf of investors who purchased Blyth, Inc. (NYSE: BTH) stock between March 14, 2012 and November 6, 2012.

(Logo:  http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

For more information, click here: http://zlk.9nl.com/blyth-bth .  You have until January 12, 2013 to request that the Court appoint you as lead plaintiff.

Zillow, Inc.

Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Western District of Washington on behalf of investors who acquired Zillow, Inc. (Nasdaq: Z) stock between February 15, 2012 and November 6, 2012.

For more information, click here: http://zlk.9nl.com/zillow-z/.  You have until January 28, 2013 to request that the Court appoint you as lead plaintiff.

SinoHub, Inc.

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased SinoHub, Inc. (OTC: SIHI) stock between May 17, 2010 and August 21, 2012.

For more information, click here: http://zlk.9nl.com/sinohub-sihi/ .  You have until January 21, 2013 to request that the Court appoint you as lead plaintiff.

Peregrine Pharmaceuticals, Inc.

Levi & Korsinsky is investigating potential claims on behalf of purchasers of Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities concerning possible breaches of fiduciary duty in connection with the disclosure of the discovery of major discrepancies in the treatment group of its Bavituxmab Phase II Second-Line Non-Small Cell Lung Cancer Trial.

1 2 Next › Last »